Banner Image

Test Directory

Beta-2 Transferrin

Test Summary

Presence of Beta-2 Transferrin (B2T) in nose and ear secretions is indicative of cerebrospinal fluid (CSF) leakage. B2T is used as a marker of CSF leakage for the diagnosis of rhinorrhea or otorrhea as a result of head trauma, tumor, congenital malformation, surgery etc. Prompt diagnosis and localization helps localization and life-threatening CNS infections.

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

0.5 mL body fluid collected in a sterile, plastic, leak-proof transport tube

Minimum Volume

0.2 mL

Instructions

• Indicate specimen source
• If direct collection is not feasible, specimen may be collected using plain cotton swab and submitted in a sterile, plastic leak-proof transport tube.
• If submitting syringe, remove needle and cap the syringe to avoid specimen leakage.
• Do not collect specimen with a culture swab.
• Do not add any liquid to the swab.

Additional Information
• Specimens contaminated with salivary fluid degrade the beta-2 transferrin. These specimens should be frozen immediately following collection and should be kept frozen until testing is performed.
• Specimens collected with additives yield uninterpretable results and will be rejected.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 15 days
  • Refrigerated: 30 days
  • Frozen: 60 days

Limitations

N/A

Other Acceptable Specimens

See Collection Instructions

Unacceptable Specimens

Specimens collected with additives

Order Code

B2TRAN

EPIC (Premier) Code

LAB3064

Includes

N/A

CPT Code

  • 86335

Billing Code

  • 670573

CPT Statement

Methodology

Electrophoresis • Immunofixation

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

Not detected

Setup Schedule / Expected Turnaround Time

Daily; Report available: 1 - 2 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

0.5 mL body fluid collected in a sterile, plastic, leak-proof transport tube

Minimum Volume

0.2 mL

Instructions

• Indicate specimen source
• If direct collection is not feasible, specimen may be collected using plain cotton swab and submitted in a sterile, plastic leak-proof transport tube.
• If submitting syringe, remove needle and cap the syringe to avoid specimen leakage.
• Do not collect specimen with a culture swab.
• Do not add any liquid to the swab.

Additional Information
• Specimens contaminated with salivary fluid degrade the beta-2 transferrin. These specimens should be frozen immediately following collection and should be kept frozen until testing is performed.
• Specimens collected with additives yield uninterpretable results and will be rejected.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 15 days
  • Refrigerated: 30 days
  • Frozen: 60 days

Limitations

N/A

Other Acceptable Specimens

See Collection Instructions

Unacceptable Specimens

Specimens collected with additives

Billing

CPT Code

  • 86335

Billing Code

  • 670573

CPT Statement

Result Information

Methodology

Electrophoresis • Immunofixation

Testing Laboratory

N/A

Reference Range

Not detected

Setup Schedule / Expected Turnaround Time

Daily; Report available: 1 - 2 days